BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17407218)

  • 1. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation.
    Moder KG; Wener MH; Weisman MH; Ishimori ML; Wallace DJ; Buckeridge DL; Homburger HA
    J Rheumatol; 2007 May; 34(5):978-86. PubMed ID: 17407218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted pattern recognition of autoantibody results.
    Binder SR; Genovese MC; Merrill JT; Morris RI; Metzger AL
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1353-7. PubMed ID: 16339056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
    Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
    J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoantibodies and peripheral arterial occlusive disease].
    Kroeger K; Kreuzfelder E
    Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of antinuclear antibodies].
    Swaak AJ
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
    Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
    J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
    Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
    Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
    Chopra A; Anuradha V; Edmonds J
    J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series.
    West M; Jasin HE; Medhekar S
    Semin Arthritis Rheum; 2006 Jun; 35(6):344-8. PubMed ID: 16765710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
    Copple SS; Martins TB; Masterson C; Joly E; Hill HR
    Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric Analysis of Connective Tissue Disease Specific Autoantibodies Using a Spot Immunoassay.
    Röber N; Rejzek M; Aringer M; Rudolph S; Unger L; Lüthke K; Gräßler A; Conrad K
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology].
    Uto K; Hayashi N; Kinoshita S; Kawano S; Kumagai S
    Rinsho Byori; 2009 Oct; 57(10):941-53. PubMed ID: 19928490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Jo-1 antibodies.
    Zampieri S; Ghirardello A; Iaccarino L; Tarricone E; Gambari PF; Doria A
    Autoimmunity; 2005 Feb; 38(1):73-8. PubMed ID: 15804708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.